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Abstract
Background: Ultra high throughput sequencing (UHTS) technologies find an important application in targeted
resequencing of candidate genes or of genomic intervals from genetic association studies. Despite the extraordinary
power of these new methods, they are still rarely used in routine analysis of human genomic variants, in part because of the
absence of specific standard procedures. The aim of this work is to provide human molecular geneticists with a tool to
evaluate the best UHTS methodology for efficiently detecting DNA changes, from common SNPs to rare mutations.
Methodology/Principal Findings: We tested the three most widespread UHTS platforms (Roche/454 GS FLX Titanium,
Illumina/Solexa Genome Analyzer II and Applied Biosystems/SOLiD System 3) on a well-studied region of the human
genome containing many polymorphisms and a very rare heterozygous mutation located within an intronic repetitive DNA
element. We identify the qualities and the limitations of each platform and describe some peculiarities of UHTS in
resequencing projects.
Conclusions/Significance: When appropriate filtering and mapping procedures are applied UHTS technology can be safely
and efficiently used as a tool for targeted human DNA variations detection. Unless particular and platform-dependent
characteristics are needed for specific projects, the most relevant parameter to consider in mainstream human genome
resequencing procedures is the cost per sequenced base-pair associated to each machine.
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Introduction
The recent commercialization of ultra high throughput
sequencing (UHTS) technologies, initially applied to the de novo
characterization of small genomes, is rapidly challenging the
classical methods of human genetic research as well. The
possibility of obtaining nucleotide sequences in the range of
hundreds of millions base pairs from various types of DNA
templates allows for example to extend mutational screenings to
very large portions of the genome, an experimental strategy that
would be too expensive and time consuming to perform with
methods based on the Sanger procedure [1]. Thanks to UHTS,
intronic and non-coding regions as well can theoretically be
included in routine resequencing processes (i.e. the analysis of a
DNA region for which a reference sequence is already known) of a
particular candidate gene or linkage interval, with minimal
additional costs and by a more complete approach with respect
to classical exon-PCR and sequencing.
However, these ‘‘next-generation’’ technologies still have some
limitations that must be taken into account. A well-recognized
problem associated with the mapping of UHTS sequences is
represented by the presence of repetitive elements or low-
complexity stretches to which short UHTS reads cannot uniquely
align [2,3]. To simplify assembly procedures of short sequencing
reads, these DNA segments are therefore generally excluded, with
the consequence of missing important disease-associated variants
present in intronic or extra-genic areas.
Recently, we discovered a mutation (c.1347+654C.G) in one
of these particular regions of the human genome associated with
dominant retinitis pigmentosa, an hereditary blinding disease [4].
This single-base substitution is comprised in a repetitive element
(variable number of tandem repeats, or VNTR) located within an
intron of the PRPF31 gene. As a proof of concept for UHTS to be
used in routine human genetic screenings, we sequenced 31 kb of
the human chromosome 19 encompassing the PRPF31 region in a
patient with this rare mutation as well as several common SNPs.
For comparative purposes, we used the three currently most
widespread UHTS platforms: Roche/454 GS FLX Titanium
(Roche 454), Illumina/Solexa Genome Analyzer II (Illumina GA)
and Applied Biosystems/SOLiD 3 (ABI SOLiD) instruments.
The Roche 454 technology is based on the clonal amplification
of DNA fragments attached on individual beads in an emulsified
PCR reaction. The beads are distributed on a 1.6 million wells
substrate (PicoTiterPlateTM) where pyrosequencing reactions
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occur [5]. The most noticeable advantage of the Roche 454
platform is the large size of the reads produced (up to 500 nt),
while Illumina GA and ABI SOLiD produce shorter reads (34 and
50 nt, at the time this research was performed). In the Illumina
GA system the amplification step is achieved on the glass surface
that covers the flow cell (bridge amplification) and the sequencing
reactions are performed by using the ‘‘reversible terminator’’
chemistry [6]. ABI SOLiD is similar to Roche 454 in the
amplification step (emulsified beads) but is unique for its ligase-
dependent sequencing chemistry, based on multiple cycles of
hybridization and ligation. The main advantage of ABI SOLiD is
constituted by the possibility of reading each base twice by
independent events, which provides internal error correction and
enables higher accuracy, especially in SNP calling [7].
Materials and Methods
Ethics statement
This study was carried out in accordance with the tenets of the
Declaration of Helsinki and was approved by the Institutional
Review Boards of our University and of Harvard Medical School,
where the blood was collected and the cell line derived. Written
informed consent was obtained from the patient who participated
in this study and donated her blood for research.
Sample preparation
We extracted DNA from a lymphoblastoid cell line derived
from an affected individual carrying the PRPF31 c.1347+654C.G
mutation (cell line #13189) and amplified the 31-kb NDUFA3-
PRPF31 genomic region by 4 individually-amplified long-range
PCR, designed as previously described [4] (Fig. 1). We specifically
selected this region to have a well characterized reference
sequence to compare our experimental results to. The following
minor modifications were introduced to the original amplification
protocol. Each PCR was performed in a final reaction volume of
10 ml, containing 1X GC Buffer I (TaKaRa, Otsu, Shiga, Japan),
0.4 mM dNTPs, 0.2 mM primers (each), 0.5 U of TaKaRa LA
Taq (TaKaRa) and 100 ng of DNA. Such an amount of genomic
template DNA allows virtually eliminating the possibility that
errors introduced by the Taq polymerase are detected in
subsequent sequencing procedures. Reactions were incubated at
94uC for 1 min, followed by 35 cycles of 98uC for 5 sec and 68uC
for 17 min, and a final elongation step of 72uC for 10 min. After
agarose gel analysis and quantification, the four PCR fragments
were pooled together and processed for downstream applications.
Library preparation and sequencing
Preparation of DNA libraries was performed following the
guidelines provided by the manufacturers of each platform and
sequenced by using: 1/8 of a plate for the Roche 454 Genome
Sequencer FLX, Titanium series, 1 lane of an Illumina Genome
Analyzer version II, and 1 ‘‘quad’’ of an ABI SOLiD 3 instrument.
The exclusion of reads with very low quality was performed
automatically by the Roche 454 and Illumina GA sequencing
instruments, while for ABI SOLiD this had to be carried out a
posteriori with the ABI’s csfasta_quality_filter.pl application,
available from the SOLiD Software Development Community.
Alignment and analysis of reads
All analyses and statistics on quality-filtered reads were
performed using the relevant tools of the software package CLC
Genomics Workbench, version 3.7 (CLC bio, Denmark) as
described below.
Trimming. In this process the parts of the reads with low
quality scores were trimmed. The algorithm calculated base error
probabilities based on their quality values, normalized to a PHRED
scale. We set a cutoff value of 0.01, calculated as described in the
software package manual, and discarded trimmed reads below
20 nt of length, independently from their residual score.
Assembly. The original reads as well as the trimmed sets
were aligned to 31 kb of the corresponding reference sequence
(NC_000019.8: 59,297,572-59,328,826). To ensure uniformity, we
applied comparable settings to all platforms, considering the
different read length of each platform, inclusive of the color-space
option for the ABI SOLiD platform. Specifically, we used the local
gapped alignment algorithm for all alignments, keeping the default
parameters for mismatch and deletion costs. Reads that aligned to
more than one position of the reference sequence were discarded.
For the intronic repetitive DNA fragment we also re-assembled
the reads by using a de novo assembly procedure. The original reads
were first aligned onto the Sanger-obtained sequence of the region
by using the same parameters described above and by allowing
random matches of reads with multiple mapping positions.
Subsequently, we extracted the sequences that aligned to the
region and used them for de novo assembly with the same
parameters used for the reference assembly (no random matches).
Detection of variants. Variant detection was performed with
the SNP and INDEL detection tools. The settings for calling a
variant were described previously by Harismendy et al. [8]: if
heterozygous, 20%–80% of the reads covering a particular
nucleotide had to contain the alternative base with respect to the
reference sequence; if homozygous, more than 80% of the reads had
to contain the alternative allele. To test the limits of SNP detection,
discovery by setting a minimum variant threshold of 10% was also
performed. The minimum coverage allowed to call a SNP was of 15
reads for a given base. We applied the default restrictions on SNP
calling: the average quality of the central base was set to 20 (PHRED
score, corresponding to a base accuracy of 99%), the average quality
Figure 1. Schematic representation of the 31-kb genomic interval analyzed, containing the genes NDUFA3, TFTP, and PRPF31. Double-
headed arrows indicate the position of the 4 amplicons used as template for UHTS.
doi:10.1371/journal.pone.0013071.g001
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of the surrounding 10 bases was 20, and the maximum number of
mismatches or indels accepted within an 11-nt window was 3. Low
quality reads were removed from the calculation of SNP frequency
and coverage and the un-aligned parts of a read counted as
mismatches. We considered a variant as real if it was validated by
Sanger or, in absence of Sanger validation, if it was found in at least
one platform and previously annotated, or independently present in
at least 2 platforms and not annotated. For the detection of indels we
used the same criteria as for SNP detection.
Coverage simulation
We simulated different coverage depths by randomly sampling a
subset of the reads from the *.fastq files exported after the
trimming process. Each subset was sampled 3 times. Alignments to
the reference sequence were performed as described above for the
non-simulated sets of data. In order to have a balanced
representation of the 4 amplicons, we calculated the average
coverage at the level of the amplicons (and not of the entire region)
and joined the amplicons with the same average coverage,
considering them as a single (artificial) sampling event. For SNP
detection we maintained the same parameters as for the full
dataset, but with a minimum coverage of 5 and at least 2 reads
carrying the variant allele, to compensate for the reduced coverage
introduced by the simulations.
Sanger sequencing
Data from the Sanger sequencing of the PRPF31 gene were
available from previous analyses [4]. Additional SNPs located
outside of the PRPF31 gene were sequenced starting from the long-
range PCRs used as UHTS templates or from short-range PCRs
obtained using standard HotStartTaq DNA polymerase (Qiagen,
Venlo, The Netherlands) protocols. PCR products were enzimati-
cally purified using 1 ml ExoSAP-IT (USB, Cleveland, Ohio USA)
for 10-ml reactions, according to the manufacturer’s instructions.
Sequencing reactions were performed by mixing 5 ml of purified
PCR product, 0.75 mM of 20mer primers and 1 ul of BigDye
Terminator v1.1 cycle sequencing kit (Applied Biosystems, Foster
City, CA), and run on a ABI-3130XLS (Applied Biosystems).
Results
General considerations on the processing and analysis of
the reads
All computer-based analyses were performed with a commer-
cial, user-friendly software. This choice was taken in order to be as
close as possible to the setup of the average laboratory performing
routine genetic testing without the specific support of computer
analysts. The use of a simple pipeline, compatible with outputs
generated by different sequencing platforms, also allowed treating
the data in a uniform manner, thus eliminating possible biases
deriving from machine-specific software or algorithms.
Sequencing and trimming of the reads
For our analyses we used 1/8 of the total sequencing capabilities
of each machine. The Roche 454 platform (1 sector of the 8-sector
gasket) generated ,100,000 quality-passed reads with an average
length of 318 nt, Illumina GA (1 lane) ,4.6 million reads of 34 nt,
and ABI SOLiD (1 ‘‘quad’’) ,17,3 million reads of 50 nt,
corresponding to a throughput of ,32 Mb, ,157 Mb and
,862 Mb, respectively (Table 1). We did not consider the option
of using paired reads, since this technique would not provide any
justified benefits to the analyses made on our standard resequen-
cing project, given the absence of major genomic rearrangement
or the necessity of creating a de novo assembly.
All raw sequences underwent quality filtering procedures
consisting in the trimming of low quality nucleotides from the
reads. After this procedure, 27.2% of the bases from the original
throughput were discarded from the Roche 454 dataset, 12.4%
from the Illumina GA dataset, and 38.0% from the ABI SOLiD
dataset. However, despite the variable number of nucleotides that
were rejected, for all platforms the large majority of the reads
(.99.8%) were not eliminated, but simply shortened (Table 1, Fig.
S1). This outcome changed when, during the trimming procedure,
not only the quality of the reads, but also its length was considered.
By imposing a minimal size of 20 nt, following the rationale that
high-score reads of a few nucleotides are useless for practical
resequencing applications, Roche 454 was left with .99.6%,
Illumina GA with the 92.1%, and ABI SOLiD with the 78.7% of
the original number of reads, corresponding to a loss of 27.2%,
15.8%, and 43.5%, respectively, in terms of nucleotides.
Alignment to the targeted interval
Trimmed sequences, as well as un-trimmed ones, were mapped
to the reference sequence (ref_seq). Since the number and the
length of trimmed reads was lower with respect to raw reads, the
total amount of bases from trimmed sequences mapping to the
ref_seq was also lower. However, trimmed reads mapped to the
ref_seq in higher percents, as a consequence of their increased
content in high-quality bases, with the effect of producing in
principle more accurate consensus sequences (Table 2). These
Table 1. Sequence throughput obtained with the three UHTS platforms analyzed.
Sequencing
technology Reads Count Discarded reads
Average length
of a read (nt) Bases Trimmed bases
Roche 454 (1/8) Total (raw) 99,317 318 31,615,489
After trimming 99,317 0.00% 232 23,010,105 27.2%
After trimming (.20 nt) 98,975 0.34% 232 23,005,448 27.2%
Illumina GA (1 lane) Total (raw) 4,611,113 34 156,777,842
After trimming 4,610,388 0.02% 30 137,405,021 12.4%
After trimming (.20 nt) 4,245,639 7.9% 31 132,052,133 15.8%
ABI SOLiD (1 quad) Total (raw) 17,287,756 50 862,377,074
After trimming 17,287,610 0.00% 31 534,615,489 38.0%
After trimming (.201 nt) 13,597,456 21.3% 36 487,053,627 43.5%
doi:10.1371/journal.pone.0013071.t001
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observations were particularly relevant for Roche 454 and ABI
SOLiD alignments, rather than Illumina GA, since the latter was
less affected by the trimming process.
The selected interval was entirely covered using the three
datasets, with the exception of 2 very small gaps originating from
non-overlapping PCRs (Figs. 1 and 2), a 8-nucleotide gap (position
18,837-44 of the ref_seq) present in the assembled sequence from
Illumina GA reads, and 3 small gaps in long homopolymeric
stretches in the assembly of Roche 454’s trimmed reads (positions
9135-40, 9313-17, 10723-36). The VNTR present in intron 13 of
the PRPF31 gene also presented platform-specific gaps, as detailed
below.
Coverage varied depending on the specific LR-PCR product
analyzed, because of uneven loading of the individual PCR
products (Fig. 2). Similar to the effect of naturally-occurring copy
number variants (CNVs) or large-scale deletions, coverage across
the analyzed region displayed sudden changes, highlighting at the
same time the boundaries between different LR-PCR products.
Coverage also varied widely across platforms (Table S1), as a
direct effect of the different throughput of the 3 sequencers. High
coverage variation also occurred within the same PCR (coefficient
of variation for local alignments of untrimmed reads: 0.46 Roche
454, 0.41 Illumina GA, 0.56 ABI SOLiD, Table S1), with a strong
bias for the amplicons ends (Fig. 2), a well-known artifact of UHTS
[9]. As expected, the average coverage for each amplicon
decreased when trimmed sets were used, although it was still
much higher than the one required for confident ascertainment of
heterozygous genetic variations, estimated by others to be
approximately in the range of 10- to 40-fold [6,7,10,11]. In
downstream analyses, we kept saturating coverage values to ensure
a reliable comparison across platforms and to avoid differences
due to stochastic variations of single base coverage.
Read Accuracy
To evaluate the accuracy of a base call in each platform after
the alignment procedure, we used the ‘‘conservation’’ score,
generally used in relationship to alignments of sequences
originating from different species. In a resequencing context and
as defined by the software package used, this value indicates the
percent of the most represented base across the reads covering the
same nucleotide in a sequence. An alignment at a given position
would have a conservation score of 100% if all the reads carry the
same base. For sake of simplicity, to compare the three alignments
we selected only one PCR fragment (amplicon #3, ,8 kb),
brought to a simulated average coverage of ,250x by using
sampled trimmed reads. This procedure also allowed evaluating
reads that were already filtered by quality scores. The average
conservation values were similar across the three platforms
(99.38% for Roche 454, 99.56% for Illumina GA, and 99.72%
for ABI SOLiD,). However, important differences appeared when
values at each position were individually ascertained. In short-read
assemblies almost all nucleotides had perfect conservation, with
some outliers corresponding to heterozygous SNPs (around 50%).
In the long-read assembly the number of outliers was higher,
especially within the 80–100% range (Fig. 3). In this latter case, the
less conserved positions of the manually-inspected bases were
associated with homopolymers stretches and corresponded to
either an incorrectly called base or, more frequently, to a gap.
SNP detection
For comparative analysis of SNP detection performances we
considered neither the intronic VNTR containing the PRPF31
pathogenic mutation, nor another VNTR in the TFTP gene, also
present in this region.
The number of SNPs identified by setting an allelic threshold of
20% was very similar across all platforms (Table 3). Decreasing the
detection threshold to 10% allowed identifying a few more real
variants (confirmed by Sanger sequencing), but also 11 more false
positives in the Roche 454 and 1 in the Illumina GA datasets, all in
correspondence of homopolymeric traits (Table S2). No false
positives were detected in ABI SOLiD sequences, even when the
threshold was lowered to 10%. Performance in SNP detection was
not significantly affected by the use of trimmed vs. raw reads,
except for Roche 454 alignments, where the trimming process
decreased the number of false positives. This was probably due to
the reduction of the coverage below the minimal threshold needed
to call a SNP, operated by the trimming procedure itself.
For some heterozygous SNPs, mostly located within the 2nd
long range PCR fragment, the number of reads relative to one
allele was substantially higher with respect to reads belonging to
the other one. This effect was particularly visible for the short-read
platforms, to a point that the experimental results did not allow a
clear detection of the variant, or a clear ascertainment between
homozygous and heterozygous SNPs (Table S3). Electrophero-
grams from Sanger sequencing of the same PCR products used as
sequencing template for UHTS revealed the same allelic
imbalance for some of these SNPs (at positions 7661, 8337,
8564, 9081 of the ref_seq, Table S3). However, when using PCR
products obtained by short-range PCR amplification as Sanger
sequencing template, electropherograms showed clearly heterozy-
gous peaks for these same SNPs. Taken together, these results may
represent the effects of imbalanced amplification of the two alleles
prior to sequencing [12], rather then a UHTS-specific or mapping
effect.
In all three platforms, the algorithm interpreted the duplication
of a CAAG next to an A stretch (dbSNP:5828571) as 2 SNP.
Table 2. Features of reads mapping to the 31-kb reference sequence.
Sequencing
technology
Count of
Mapped Reads
Mapped
reads
Average length of
a mapped read (nt)
Total mapped
bases
Mapped
bases
Roche 454 Full length reads (99,3 K) 62,830 63% 372.85 23,426,369 74%
Trimmed reads (98,9 K) 78,766 80% 263.45 20,751,152 90%
Illumina GA Full length reads (4,6 M) 437,1967 95% 34.00 148,646,878 95%
Trimmed reads (4,2 M) 418,3505 99% 31.14 130,291,345 99%
ABI SOLiD Full length reads (17,3 M) 14,842,743 86% 49.92 740,988,589 86%
Trimmed reads (13,6 M) 12,790,106 94% 36.00 460,470,548 95%
doi:10.1371/journal.pone.0013071.t002
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SNP detection at simulated coverage depths
Coverage simulations were performed to ascertain the presence
of features emerging from non-saturating conditions and to
determine the minimum coverage required by each platform to
detect the correct number of SNPs. We randomly sampled reads
after the filtering and trimming procedure to obtain seven average
depths (350, 250, 100, 50, 20, 15, and 10x). The average coverage
of each fragment was proportional to the number of reads of a
given length used in the assembly (data not shown), so that it was
possible to calculate the number of reads to sample from each
dataset in order to obtain the desired coverage depth.
For each simulated sequencing experiment, we counted the
number of SNPs identified. We eliminated all variants detected
having less than 5x coverage, allowing at least 2 high-quality reads
carrying the variant, since these parameters were already
ascertained to produce reliable calls [6]. We chose as ‘‘reference
set’’ of detectable SNPs the list of variants reported in Table S3,
with the exception of the two entries corresponding to the CAAG
duplication (52 SNPs in total). SNP detection following mapping at
simulated coverage depths showed some platform-specific differ-
ences in the number of variants detected as function of the average
number of reads per base (Fig. 4). However, these differences
quickly disappeared as soon as the threshold coverage value
corresponding to ,50x was reached. After this limit there was
little or no increase in the SNP discovery rate and the different
samplings show nearly-similar results. Specifically, at 50x we
detected 88% SNPs with Roche 454, and 95% SNPs with Illumina
GA and ABI SOLiD, but at higher coverage all platforms reached
a plateau score of ,95%.
False positive appeared in all three platforms. Regardless of the
simulated average coverage, they were the outcome of random
errors in sequencing that could not be corrected by additional
reads covering the same position. At lower depths, this limitation
was the obvious effect a reduced number of available reads. At
higher depths, false positives invariantly showed to have local
coverage that was at least 10 times lower than the average
(simulated) one, likely because of mapping difficulties, and thus
easily recognizable as false calls.
Insertions and deletions detection
The automated identification of small insertions and deletions
(indels) is a difficult issue both for Sanger sequencing and UHTS
technologies. One heterozygous cytosine deletion (dbSNP:
34064860) downstream of the PRPF31 gene was found in
alignments for the three platforms. For Illumina GA and ABI
SOLiD this was the only indel detected, while for the Roche 454 we
could identify 88 (Table S4) and 124 (not shown) additional
deletions spanning one to four bp when trimmed and untrimmed
Figure 3. Read accuracy evaluation, on the 3rd long-range PCR fragment (,8 kb). Values on the Y axis (conservation) indicate the fraction
of the most prevalent base at a given position, as detected from the reads covering that position. Conservation scores below 0.5 represent gaps of
the assembly with respect to the reference sequence. In the Roche 454 assembly this occurs when the majority of the reads have an indel with
respect to the ref_seq, while in the Illumina GA alignment the point at 0% conservation corresponds to a region with no coverage (position: 18,837-
44).
doi:10.1371/journal.pone.0013071.g003
Figure 2. Coverage per bp of the analyzed region, by the assembly of untrimmed reads. Solid arrowheads indicate the boundaries of each
long-range PCR amplicon, while open arrowheads show the position of the VNTR in intron 13 of PRPF31.
doi:10.1371/journal.pone.0013071.g002
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reads, respectively, were used. All of them were found in
correspondence of homopolymers stretches and were considered
as false positives. Moreover, Sanger sequencing of the PRPF1 gene
did not reveal any of the deletions detected by Roche 454 in that
interval.
No insertion was automatically found in any of the sequences
generated by the three platforms, including the CAAG duplica-
tion, ascertained with Sanger sequencing and by manually
checking the UHTS alignments (dbSNP:5828571).
Alignment to the repetitive region of PRPF31 containing
the c.1347+654C.G mutation
Repetitive regions represent more than 50% of the human
genome [13]. These elements are generally masked in large-scale
assembly processes to avoid non-specific alignment of the reads. To
overcome this problem, which could have influenced the assessment
of variant detection, reads that had multiple matches on the ref_seq
were discarded from the analyses. This resulted in lowering the local
coverage of low-complexity regions but did not create noise in
variant detection. With respect to the VNTR, coverage patterns
were not uniform and were platform-specific (Fig. 5A). Unlike reads
from Illumina GA and ABI SOLiD, sequences generated by Roche
454 could cover the whole VNTR. Thanks to their longer range,
they aligned to the non-repetitive (anchoring) flanking sequences
and therefore represented the best option for sequencing this
repetitive element. However, the reads deriving from the core
repeats had multiple matches and were eliminated, thus resulting in
the coverage dip in the corresponding region.
Figure 4. SNP discovery rate at simulated coverage depths. We tested seven average coverage depths, with three random samples for each
point. SNPs and false positive hits are indicated by filled and open symbols, respectively. Squares, Roche 454; circles, Illumina GA; triangles, ABI SOLiD.
doi:10.1371/journal.pone.0013071.g004
Table 3. Number of SNPs and false positive variants detected, after alignments of untrimmed reads.
Sequencing
technology Alignments True variants .20% False positives.20% True variants .10%* False positives.10%*
Roche 454 Full length reads 48 4 49 15
Trimmed reads 46 1 47 6
Illumina GA Full length reads 49 0 52 1
Trimmed reads 49 0 52 1
ABI SOLiD Full length reads 48 0 51 0
Trimmed reads 50 0 51 0
*Values inclusive of the elements detected with a .20% threshold.
doi:10.1371/journal.pone.0013071.t003
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An additional element of complexity typical of repetitive
elements such as VNTRs is that they are polymorphic. The
individual analyzed here was homozygous for 6 VNTR repeats,
while the ref_seq reported a VNTR carrying 7 elements. None of
the three platforms analyzed could resolve the correct structure,
which was disclosed only by Sanger sequencing. When UHTS
reads were aligned onto the correct sequence, short reads
assemblies still could not match to the central portion, although
the sizes of the gaps were reduced and more sequence could be
covered, as consequence of the increased number of uniquely-
placed reads. On the contrary, long reads could precisely map the
entire region (Fig. 5B). The same occurred also for another VNTR
located in the TFTP gene: none of the three alignments could
clearly detect two repeats present in the patient with respect to the
four repeats reported in the ref_seq.
To bypass the limitation arising from forcing an alignment to a
reference sequence, we tried also de novo assembly of the subset of
reads matching the PRPF31 VNTR (544 Roche 454’s reads,
173,824 Illumina GA’s reads, 773,064 ABI SOLiD’s reads). A
contig could be obtained only with Roche 454 reads but, as before,
the number of the repeats did not correspond to the ones of the
patient (one of them was missing).
The mutation associated with adRP in the patient was clearly
detected by all three techniques with a frequency very close to
50% and a coverage similar to the rest of the fragment and
regardless of the ref_seq used, likely thanks to its proximity with
the 59 anchoring non-repetitive region.
Discussion
To provide a proof of concept for routine genomic DNA
resequencing by UHTS, specifically focused on the detection of
disease-causing variants, we processed a 31-kb human genomic
region with three next-generation sequencing platforms and
analyzed the results with a commercial, user friendly software.
In addition to several common SNPs and other typical variants of
the human genome, this interval contained a rare mutation
located in a particularly challenging region, thus representing an
interesting benchmark for a comparative analysis.
The raw sequence throughputs obtained were consistent with
the ones expected for the portion of the sequencing area used for
each instrument, as specified by each manufacturer. For all
platforms, the reads were minimally affected by the filtering
(trimming) procedure, as only 0.2% or less of them were discarded.
However, this result cannot be taken as a practical qualitative
parameter, since reads of excellent quality but of very short length
are basically useless in resequencing procedures. When a minimal
length of 20 nt was included as a parameter in the filtering process,
the three platforms began to reveal some differences. Roche 454
conserved basically all of the original reads, in virtue of its
chemistry producing sequences much longer than 20 nt, while the
other sequencers retained only 80–90% of them. It has to be
noted, however, that this trimming procedure was heavily
dependent on the strategies used by the single platforms to
eliminate low quality and polyclonal sequences from the raw
output and has only a relative value in terms of comparison across
the different UHTS systems. For example, ABI SOLiD’s low
quality reads were not discarded a priori by the machine since this
platform relies more on quality control steps (color space) during
the mapping procedure than during the pre-filtering process.
Following mapping procedures, different platforms produced
different coverage depths per base. This was simply the result of
the initial different sequencing throughput typical of each
platform, and not an issue related to the quality of the sequences
or to the mapping procedure. Considering, however, that the same
relative sequencing surface was used for all the machines (1/8 of
the total sequencing area), mapping of Roche 454 raw reads
produced an average coverage of ,770x/base, of Illumina GA
reads ,4,000x/base, and of ABI SOLiD reads ,26,000x/base.
The throughput of each machine is constantly increasing,
following the technical development of the respective chemistries,
making it difficult to provide updated comparisons relying on real
data analyses. For example, the new released models from
Illumina (HiSeq 2000) and ABI SOLiD (version 4) can reach a
throughput of 100 Gb per run or more.
Mapping accuracy appeared to correlate with the quality of the
individual reads, rather than with parameters related to the
mapping procedure itself. Specifically, short-read platforms
produced assemblies having higher accuracy than Roche 454,
simply because this latter platform is prone to introduce errors
(especially indels) when stretches of homopolymeric bases are
present [10,14].
Once the contigs were obtained, we focused on the detection of
the human variants contained in the targeted region (SNPs, small
insertions and deletions, other polymorphisms), the principal aim
being the simulated discovery of pathogenic mutations. SNP
detection was overall comparable across the three platforms;
however, some differences could be detected. In Roche 454’s long-
read alignments, false positives and negatives (undetected SNPs)
could be again connected to the typical errors of the 454
technology, related to homopolymer effects. We observed that the
use of quality-trimmed reads could reduce these false positive calls,
but it also reduced the number of true variants automatically
Figure 5. Coverage of the PRPF31 intronic VNTR. Values shown are relative to the mapping of the original ref_seq entry containing 7 repeats (A)
or of the experimentally-determined sequence containing 6 repeats (B). Untrimmed reads are represented here because they produced the best
alignment to this repetitive element. Vertical lines show the boundaries of the VNTR.
doi:10.1371/journal.pone.0013071.g005
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detected. Nevertheless, when manually inspected, these variants
could safely be identified. Similarly, in alignments from short-read
platforms false negatives (one of which was in common between
Illumina GA and ABI SOLiD) were due to the low frequency
displayed by the ‘‘non ref_seq’’ allele, and they become detectable
when the discovery threshold was lowered. In some particular
instances, especially for Illumina GA data, the under-detection or
the incorrect calling of SNPs as homozygous or heterozygous
variants were not a consequence of UHTS errors, but could be
explained by allelic unbalanced amplification. This phenomenon
occurs when one of the two alleles is enriched during the PCR
amplification of the template DNA, or perhaps during the
amplification of the libraries, and results in a problem that is
relevant also when high coverage depths are used [8]. Notably, in
Roche 454 this unbalance was present but less pronounced,
indicating probably an inferior sensitivity to this phenomenon.
Another interesting observation is that some of the SNPs with low-
limit frequency in short-read alignments were located in regions
that presented similarities with other segments of the analyzed
interval (Fig. S2). One hypothesis could be that some of the reads
sequenced from a particular SNP were mistakenly aligned to other
similar sequences and vice-versa, lowering the frequency of
detection at the real position. Yet, in other regions of similarities
SNPs were correctly identified, leading to the notion that errors in
allelic calling due to sequence repeats may not represent an
absolute rule, especially if the noise is reduced by eliminating reads
displaying multiple matches. Taken together, these results indicate
that, despite the fact that UHTS machines produce quantitative
results, other causes may influence the detection of heterozygous
variants when standard parameters are chosen in automated
detection. However, in practical terms this issue should not
represent a major concern, as the number of SNPs that were prone
to this miscalling represented in our test only a small fraction of the
total number of heterozygous SNPs.
Sensitivity in SNP detection with respect to the coverage
increased from Roche 454 to ABI SOLiD and finally to Illumina
GA. Since the differences detected were not too pronounced and
SNP detection was heavily dependent on the regional sequence
context, we can safely conclude that all platforms analyzed can be
considered as having similar performances with respect to
sensitivity at the same average coverage. Indeed, it is very hard
to extrapolate the results from their specific sequence or random
coverage contexts, as the mapping procedure (and the corre-
sponding local coverage of a given SNP) was influenced by the
complexity of the DNA to be sequenced and the number of reads
available. At lower average coverage depths, the rate of discovery
decreased sensitively and different random samplings gave
different results because the number of poorly-covered regions
was higher. As mentioned, in correspondence of false positive calls
local coverage was low even when the average coverage depth was
high, indicating a direct influence of the mapping procedure on
automated identification of variants.
With respect to detection of small insertions and deletions, the
most relevant observation relates to the identification of a large
number of false positive deletions in homopolymers stretches
obtained with Roche 454 alignments, as also noted by others in
analyses of longer genomic intervals [8]. Considering the
importance of indels in human hereditary diseases, our experi-
ments indicate that Roche 454 sequences would require the use of
specific downstream algorithms, able to systematically detect the
presence of sequence-dependent false positives.
The c.1347+654C.G mutation in the 56-bp intronic VNTR of
PRPF31 was taken as a benchmark to assess whether ‘‘difficult’’
DNA variants could be detected by UHTS. Large-scale sequencing
projects almost invariantly clash with the problem of mapping and
carefully analyzing repetitive DNA elements [2,3]. Roche 454’s long
sequences (and presumably any newer UHTS chemistry or
technology producing extended reads) represent without doubts
the best tool for covering repetitive regions, at least for elements that
do not exceed in size the average length of ,1.5 to 2 reads. Our
results support this assumption, since the Roche 454 reads provided
the most complete coverage of both the PRPF31 and TFPT VNTRs
analyzed. Nevertheless, it was not possible to precisely resolve the
number of repeats composing these elements, neither by aligning
them to a reference sequence, nor by de novo assembly.
Conversely, despite the presence of repeats, all three platforms
tested could successfully detect the mutation associated with the
disease in the patient’s genome. This favorable outcome is
probably due to the presence of the pathogenic variant within
the first of the 6 elements composing the VNTR, thus allowing the
‘‘anchoring’’ of some reads to the non-repetitive DNA region in 59
of this repeat. Although previous attempts to identify this mutation
with an earlier version of the Illumina GA (the ‘‘GA I’’ platform)
failed in such a task [4], this can be explained by the algorithms
used for aligning Illumina reads, rather than by the improvements
made by the Solexa technology. Specifically, all software used
previously allowed random alignment of reads having multiple
matches, thus creating noise in the detection of the variant in
nearly-identical repeats.
Other rearrangements of the human genome characterized by a
variable number of large and unique DNA copies (CNVs, large
duplication and deletions, genetic amplification in cancer, etc.) are
in general easily detected by UHTS. Because of the quantitative
nature of the sequencing results, such rearrangements produce
very noticeable variations of coverage when aligned to a ref_seq.
For example, CNVs, sparse and non-repetitive elements spanning
kilobases to megabases of DNA [15], are simply detected as
sudden variations of the coverage by all UHTS platforms analyzed
here [7,11,16,17].
The increase of read length in UHTS platforms, an issue on
which manufacturers are putting constant efforts, will probably
help reducing some of the current weaknesses of this technology
and accelerate the transition from Sanger sequencing to UHTS.
Illumina, for example, has increased the length of the reads from
35 nt to 100 nt in less than a year; ABI SOLiD, from 50 to 75 nt.
However, if we exclude repeats-related concerns, our data seem to
indicate that this ever changing dimension in UHTS systems
should not have a major impact on DNA variants detection in
resequencing efforts (since the reference sequence is known
already), whereas the quality of the reads produced should.
Hence, the data produced here can very likely be extrapolated to
future longer reads from the same platforms, provided that the
sequencing chemistry and procedures remain the same.
In our analysis we did not consider the costs of sequencing as a
comparative parameter, although it obviously represents an
important factor to be taken into account while designing a
sequencing project. From our results, no striking qualitative
difference appeared across the three platforms, when appropriate
conditions in terms of reads and coverage depths were fulfilled. As
a general rule then, the less expensive platform producing the
needed amount of sequences for a given project would probably
also be the most suitable one, unless platform-specific character-
istics (e.g. long reads, usable throughput, etc.) are critical for the
tests to be carried out or other endeavors with respect to genomic
DNA resequencing (e.g. transcriptome sequencing) are performed.
In conclusion, in our work we show that identification of DNA
variants in complex DNA sequences such as the human genome can
be achieved by highly-parallel techniques, with investments in terms
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of cost and time that represent a fraction of what is usually spent for
conventional sequencing. Furthermore, our successful adoption of a
user-friendly software and a straightforward analytical pipeline
demonstrates that a strong bioinformatic background is not a
compulsory requirement for investigators dealing with UHTS
technology. In our example, we performed the analysis of a large
genomic region from a single individual amplified by LR-PCR.
However, the power of UHTS can be applied to sequence shorter
DNA regions obtained by sequence capture or conventional PCR in
multiple patients, i.e. to a procedure that is more similar to current
routine setups in medical genetic laboratories. Although some
limitations to this latter UHTS application still exist, the use of
sample pooling [18,19] and individual DNA barcoding
[20,21,22,23] is now facilitating the adoption of highly-parallel
sequencers by conventional genetic labs. Taken together, our data
indicate that the so-called ‘‘next-generation’’ sequencing, regardless
of the platform used, can be efficiently and safely used by the current
generation of human geneticists as well.
Supporting Information
Figure S1 Distributions of read lengths from the three platforms
tested. The output generated from short-read platforms consists in
reads having the same length: Illumina GA generated only reads of
34 nt and ABI SOLiD generated mostly reads of 50 nt, with only
a small fraction of them (0.4%) having shorter lengths.
Found at: doi:10.1371/journal.pone.0013071.s001 (0.61 MB TIF)
Figure S2 Similarity plot of the region analyzed. The VNTRs
within the TPFT and PRPF31 sequences are indicated by arrows.
Vertical lines (corresponding horizontal lines are omitted) indicate
the position of SNPs rs35705606 and rs2668836 at coordinates
13,761 and 14,098, respectively, that were under-detected by short
read platforms.
Found at: doi:10.1371/journal.pone.0013071.s002 (7.67 MB TIF)
Table S1 Coverage of individual amplicons.
Found at: doi:10.1371/journal.pone.0013071.s003 (0.05 MB
DOC)
Table S2 Details on false positive results detected, after assembly
of untrimmed reads.
Found at: doi:10.1371/journal.pone.0013071.s004 (0.06 MB
DOC)
Table S3 SNPs detected after mapping of UHTS untrimmed
reads. Black: SNPs detected by using the default threshold for
heterozygozity (20%). Red: SNPs detected with a threshold
between 10% and 20%. Blue: SNPs with a borderline limit
definition of homo-heterozygosity. Green: variants corresponding
to the CAAG insertion. Grey shadow: SNPs located in the 2nd
long range PCR fragment, showing allelic imbalance. SNPs
identified in the tandem repeats are not reported.
Found at: doi:10.1371/journal.pone.0013071.s005 (0.22 MB
DOC)
Table S4 Deletions detected with Roche 454 (false positives),
using trimmed reads. The deletion at position 30,672 was also
found using the other 2 platforms, likely being the only real small
deletion.
Found at: doi:10.1371/journal.pone.0013071.s006 (0.16 MB
DOC)
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